PDCD1 and glioblastoma: Interestingly, PD-1 expression level in CD4+ CAR-T cells was associated with engraftment and progression-free survival in glioblastoma patients receiving EGFRvIII CAR-T cell therapy (22), suggesting correlations between PD-1 expression and CAR-T cell therapeutic response may be disease type specific.